Keywords: Bayer HealthCare, Max Planck, Colon cancer, OncoTrack, Biomarkers

Bayer leads massive industry/academia consortium for colon cancer research

Article | 11 March 2011

Print This

OncoTrack, an international consortium of over 60 scientists, managed by Bayer HealthCare Pharmaceuticals, part of Germany’s Bayer AG (BAY: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in